Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.90
-0.08 (-4.04%)
At close: Aug 15, 2025, 2:14 PM
Spero Therapeutics Fail-to-Deliver
Total FTD Shares
256.3K
Above Average
FTD / Avg. Volume
5.57%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
Spero Therapeutics Inc. has
256,298
shares failed to deliver, representing 5.57%
of the average daily volume of
4,600,548
shares. Over the past year, the monthly average FTD is
22,919
shares, with the current level 1018% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 11, 2025 | 2.81 | 256.3K | +2135716.67% |
| Jun 30, 2025 | 2.9 | 12 | -99.85% |
| May 30, 2025 | 2.5 | 8.23K | +205600.00% |
| Apr 25, 2025 | 0.7252 | 4 | -92.98% |
| Mar 12, 2025 | 0.7486 | 57 | -71.50% |
| Jan 14, 2025 | 0.9742 | 200 | +19900.00% |
| Dec 27, 2024 | 1.03 | 1 | -99.87% |
| Nov 26, 2024 | 1.13 | 794 | -99.31% |
| Oct 09, 2024 | 1.24 | 114.72K | +1083.53% |
| Aug 14, 2024 | 1.22 | 9.69K | +20.22% |
| Jul 18, 2024 | 1.42 | 8.06K | +288.58% |
| Jun 27, 2024 | 1.34 | 2.08K | +406.10% |
| May 23, 2024 | 1.48 | 410 | -88.92% |
| Apr 29, 2024 | 1.44 | 3.7K | -77.64% |
| Mar 25, 2024 | 1.69 | 16.54K | +739.80% |
| Feb 29, 2024 | 1.65 | 1.97K | +1006.74% |
| Jan 31, 2024 | 1.52 | 178 | +206.90% |
| Dec 26, 2023 | 1.45 | 58 | +190.00% |
| Nov 30, 2023 | 1.14 | 20 | -9.09% |
| Oct 23, 2023 | 1.05 | 22 | -71.79% |
| Sep 29, 2023 | 1.21 | 78 | -91.72% |
| Aug 14, 2023 | 1.37 | 942 | -81.39% |
| Jul 28, 2023 | 1.42 | 5.06K | +1165.75% |
| Jun 23, 2023 | 1.6 | 400 | -93.69% |
| May 31, 2023 | 1.74 | 6.34K | +548.16% |
| Apr 25, 2023 | 1.69 | 978 | -81.92% |
| Mar 29, 2023 | 1.45 | 5.41K | +247.11% |
| Feb 24, 2023 | 1.51 | 1.56K | -89.37% |
| Jan 30, 2023 | 1.83 | 14.65K | n/a |